BNP Paribas Reiterates Outperform Rating for Shire PLC

BNP Paribas Reiterates Outperform Rating for Shire PLC


's stock had its "outperform" rating reissued by equities researchers at BNP Paribas in a report released on Monday. They presently have a GBX 5,700 price objective on the biopharmaceutical company's stock.



from Biotech News